Agnogenic Myeloid Metaplasia
5 clinical trials · Condition
◉ Watch Agnogenic Myeloid Metaplasia
| Record | Firm | Date |
|---|---|---|
| A Phase 1 Study of MKC-1 in Patients With Refractory Hematologic Malignancies (NCT00506402) | CASI pharmaceuticals, Inc. | 2006-11-01 |
| Dasatinib as Therapy for Myeloproliferative Disorders (MPDs) (NCT00255346) | M.D. Anderson Cancer Center | 2005-11-15 |
| PTK 787 and Gleevec in Patients With AML, AMM, and CML-BP (NCT00088231) | M.D. Anderson Cancer Center | 2004-07-01 |
| A Study of Gleevec in Patients With Idiopathic Myelofibrosis or Chronic Myelomonocytic Leukemia (CMML) (NCT00136409) | Dana-Farber Cancer Institute | 2002-05-01 |
Track Agnogenic Myeloid Metaplasia automatically
Every clearance here is in the API, with alerts when new ones post.